Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.

about

Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.

Item

http://www.wikidata.org/entity/Q52390750

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.

@en

Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.

@nl

type

Item

label

Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.

@en

Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.

@nl

prefLabel

Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.

@en

Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.

@nl

P1476

Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.

@en

P2093

Craig L Duvall

http://www.w3.org/2001/XMLSchema#string

Dana M Brantley-Sieders

http://www.w3.org/2001/XMLSchema#string

Donna J Hicks

http://www.w3.org/2001/XMLSchema#string

Linus H Lee

http://www.w3.org/2001/XMLSchema#string

Meghan Morrison Joly

http://www.w3.org/2001/XMLSchema#string

Meredith A Jackson

http://www.w3.org/2001/XMLSchema#string

Paula Gonzalez Ericsson

http://www.w3.org/2001/XMLSchema#string

Rebecca S Cook

http://www.w3.org/2001/XMLSchema#string

Samantha M Sarett

http://www.w3.org/2001/XMLSchema#string

Shan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)

Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy

mTOR: from growth signal integration to cancer, diabetes and ageing

mTOR signaling in growth control and disease

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer

mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis

Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown.

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

P304

1845-1858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-17-2388

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kameron V Kilchrist

P577

2018-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29358172

http://www.w3.org/2001/XMLSchema#string

P932

5882532

http://www.w3.org/2001/XMLSchema#string